Dr Carmen Criscitiello speaks at EONS 10, opening the session with a poll of attendees to assess current understandings and awareness of CDK 4/6 therapies.
CDKs were also discussed at an ecancer symposium at ESMO 2016.
Supported by a grant from Pfizer Inc.